Cargando…
Development of Tumor Cell-Based Vaccine with IL-12 Gene Electrotransfer as Adjuvant
Tumor cell-based vaccines use tumor cells as a source of tumor-associated antigens. In our study, we aimed to develop and test a tumor vaccine composed of tumor cells killed by irradiation combined with in vivo interleukin-12 gene electrotransfer as an adjuvant. Vaccination was performed in the skin...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157224/ https://www.ncbi.nlm.nih.gov/pubmed/32121641 http://dx.doi.org/10.3390/vaccines8010111 |